Unanswered Questions Remain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A discusses the FDA’s investigation into the possible association between CAR-T cell therapy and secondary T-cell malignancies.

John listerDrug administrationAllegheny health network cancer instituteCellular therapyBenefits outweigh risksKnow aboutUnanswered questions remainMultiple myeloma